ALMEDALEN. Erik Gatenholm, which is one of the founders of start-up company Cellink awarded the Future Prize 2016, which goes to a young and promising entrepreneur. The prize is awarded by including new technologies.
Cellink has developed an ink that allows to print biological tissue in the company’s proprietary 3D-printer. The ink is made of nanocellullosa and mixed with the type of cells being examined.
Tests of medicines and cosmetics can be made on the printed tissue rather than in experimental animals. A long-term goal is to print human spare parts.
Cellink was one of the companies on the New Technique 33 list last spring. Since then, in March, the number of employees increased from five to eight. The young company has also moved from its 20 square meters of combined manufacturing and office space to more than twice the area of biotech house at Chalmers.
– It’s happened so much since we were on the 33 list. Sales have increased substantially, we have sold for 4.4 million this year, says a delighted Future Laureates.
New customers are located in Singapore, Japan, Taiwan, South Korea and China. The plan – We want to become Sweden’s next big bet, says Erik Gatenholm.
Its customers include universities and companies. Now we are looking for partner companies, such as have leading roles globally and in reducing the number of animals in the long term.
At the awards ceremony in Almedalen was also Cellinks tissue expert Hector Martinez. He is the brain behind the 3D-printer, and underlines how good it is the advantage of continuing to build themselves, and not add the production abroad.
– Then we have an eye on quality and that is important, says Hector Martinez .
the prize of SEK 100 000 will focus on leadership skills in the company. Future Prize awarded by Ny Teknik, Swedbank, technology companies, energy companies and Nature Conservation.
No comments:
Post a Comment